A Novel Score Predicts HBV-Related Hepatocellular Carcinoma Recurrence After Hepatectomy: a Retrospective Multicenter Study

2018 ◽  
Vol 23 (5) ◽  
pp. 922-932 ◽  
Author(s):  
Wei Qin ◽  
Li Wang ◽  
Beiyuan Hu ◽  
Shusheng Leng ◽  
Huan Tian ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Multicenter Study ◽  
Hepatocellular Carcinoma Recurrence ◽  
Retrospective Multicenter Study

Factors Related to Hepatocellular Carcinoma Recurrence After Liver Transplantation—A Brazilian Multicenter Study

2017 ◽  
Vol 49 (4) ◽  
pp. 863-866 ◽  
Author(s):  
M. Bina Possatto ◽  
E.C. de Ataíde ◽  
C.A. Fazzio Escanhoela ◽  
T. Sevá-Pereira ◽  
R. de Cassia Martins Alves da Silva ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Multicenter Study ◽  
Hepatocellular Carcinoma Recurrence

scholarly journals Therapeutic results of different treatments for single hepatocellular carcinoma: a retrospective multicenter study(18 institutions).

Kanzo ◽  
2000 ◽  
Vol 41 (3) ◽  
pp. 169-182
Author(s):  
Toshihito SEKI ◽  
Yukio OSAKI ◽  
Hiroshi KASUGAI ◽  
Hiroko OKA ◽  
Masatoshi KUDO ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Multicenter Study ◽  
Therapeutic Results ◽  
Retrospective Multicenter Study

scholarly journals EP-1414 SBRT for the treatment of hepatocellular carcinoma: a retrospective multicenter study

2019 ◽  
Vol 133 ◽  
pp. S768-S769
Author(s):  
N. Scher ◽  
F.G. Riet ◽  
G. Janoray ◽  
K. Debbi ◽  
S. Levy ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Multicenter Study ◽  
Retrospective Multicenter Study

scholarly journals Hepatocellular carcinoma recurrence after liver transplantation in a Brazilian multicenter study

2019 ◽  
Vol 31 (9) ◽  
pp. 1148-1156 ◽  
Author(s):  
Aline L. Chagas ◽  
Guilherme E.G. Felga ◽  
Marcio A. Diniz ◽  
Renato F. Silva ◽  
Angelo A. Mattos ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Multicenter Study ◽  
Hepatocellular Carcinoma Recurrence

scholarly journals Natural history of untreated hepatocellular carcinoma: A retrospective multicenter study of 195 patients

Kanzo ◽  
2003 ◽  
Vol 44 (11) ◽  
pp. 546-551 ◽  
Author(s):  
Hiroko OKA ◽  
Yukio OSAKI ◽  
Hiroshi KASUGAI ◽  
Masatoshi KUDO ◽  
Toshihito SEKI ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Natural History ◽  
Multicenter Study ◽  
History Of ◽  
Retrospective Multicenter Study

scholarly journals Outcome of Initial Progression During Nivolumab Treatment for Hepatocellular Carcinoma: Should We Use iRECIST?

2021 ◽  
Vol 8 ◽  
Author(s):  
Dong Ho Lee ◽  
Sangyoun Hwang ◽  
Young Hwan Koh ◽  
Kyung-Hun Lee ◽  
Ju Yeon Kim ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Immune Response ◽  
Multicenter Study ◽  
Immune Checkpoint Inhibitors ◽  
Progressive Disease ◽  
Checkpoint Inhibitors ◽  
Evaluation Criteria ◽  
Response Evaluation ◽  
Retrospective Multicenter Study ◽  
Response Evaluation Criteria

Immune response evaluation criteria in solid tumors (iRECIST) is recommended during immune checkpoint inhibitors (ICIs) treatment, due to the possibility of pseudoprogression. We evaluated the frequency of pseudoprogression in hepatocellular carcinoma (HCC) patients. This retrospective multicenter study involved 158 consecutive patients who underwent nivolumab treatment for HCC in Korea. At the initial evaluation, 94 patients presented with immune unconfirmed progressive disease, and 22 continued nivolumab. At the second evaluation, 21 of the 22 patients (95.5%) had confirmed progression and no pseudoprogression was observed. Considering low possibility of pseudoprogression, iRECIST may not be required for HCC.

Sign in / Sign up

Export Citation Format

Share Document